Does the media favor AMWL or SOPH?

In the previous week, SOPHiA GENETICS had 24 more articles in the media than American Well. MarketBeat recorded 30 mentions for SOPHiA GENETICS and 6 mentions for American Well. American Well's average media sentiment score of 0.53 beat SOPHiA GENETICS's score of 0.10 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 3 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SOPHiA GENETICS 10 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Which has better earnings & valuation, AMWL or PHR?

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.82 -$95.70M -$4.77 N/A Phreesia $480.59M 1.40 $2.31M $0.17 63.85

Is AMWL or PHR more profitable?

Phreesia has a net margin of 2.06% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.22% beat American Well's return on equity. Company Net Margins Return on Equity Return on Assets American Well -35.75% -30.12% -22.30% Phreesia 2.06% 5.22% 3.02%

Does the media prefer AMWL or PHR?

In the previous week, American Well had 1 more articles in the media than Phreesia. MarketBeat recorded 6 mentions for American Well and 5 mentions for Phreesia. American Well's average media sentiment score of 0.53 beat Phreesia's score of 0.16 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 3 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Phreesia 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer AMWL or MDRX?

American Well presently has a consensus target price of $9.50, indicating a potential downside of 23.41%. Given American Well's stronger consensus rating and higher probable upside, equities analysts clearly believe American Well is more favorable than Veradigm. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Well 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Veradigm 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, AMWL or MDRX?

Veradigm has higher revenue and earnings than American Well. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.82 -$95.70M -$4.77 N/A Veradigm $1.53B 0.41 N/A N/A N/A

Does the media favor WEAV or AMWL?

In the previous week, American Well had 4 more articles in the media than Weave Communications. MarketBeat recorded 6 mentions for American Well and 2 mentions for Weave Communications. Weave Communications' average media sentiment score of 0.63 beat American Well's score of 0.53 indicating that Weave Communications is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Weave Communications 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 3 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to NRC or AMWL?

In the previous week, National Research had 4 more articles in the media than American Well. MarketBeat recorded 10 mentions for National Research and 6 mentions for American Well. National Research's average media sentiment score of 0.96 beat American Well's score of 0.53 indicating that National Research is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Research 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive American Well 3 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

American Well (AMWL) Competitors

$12.40 -0.30 (-2.33%)

Closing price 10/12/2026 03:59 PM Eastern

Extended Trading

$12.43 +0.03 (+0.21%)

As of 10/12/2026 07:30 PM Eastern

Compare

AMWL vs. SOPH, PHR, MDRX, WEAV, and NRC

Should you buy American Well stock or one of its competitors? American Well's main competitors and comparable companies include SOPHiA GENETICS (SOPH), Phreesia (PHR), Veradigm (MDRX), Weave Communications (WEAV), and National Research (NRC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does American Well compare to SOPHiA GENETICS?

American Well (NYSE:AMWL) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

American Well currently has a consensus target price of $9.50, indicating a potential downside of 23.41%. SOPHiA GENETICS has a consensus target price of $10.00, indicating a potential upside of 38.50%. Given SOPHiA GENETICS's stronger consensus rating and higher possible upside, analysts clearly believe SOPHiA GENETICS is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

SOPHiA GENETICS has lower revenue, but higher earnings than American Well. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A
SOPHiA GENETICS	$77.27M	7.84	-$79M	-$1.15	N/A

American Well has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market. Comparatively, SOPHiA GENETICS has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

In the previous week, SOPHiA GENETICS had 24 more articles in the media than American Well. MarketBeat recorded 30 mentions for SOPHiA GENETICS and 6 mentions for American Well. American Well's average media sentiment score of 0.53 beat SOPHiA GENETICS's score of 0.10 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SOPHiA GENETICS	10 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

American Well has a net margin of -35.75% compared to SOPHiA GENETICS's net margin of -93.86%. American Well's return on equity of -30.12% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

56.1% of American Well shares are owned by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

American Well beats SOPHiA GENETICS on 9 of the 16 factors compared between the two stocks.

How does American Well compare to Phreesia?

American Well (NYSE:AMWL) and Phreesia (NYSE:PHR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A
Phreesia	$480.59M	1.40	$2.31M	$0.17	63.85

In the previous week, American Well had 1 more articles in the media than Phreesia. MarketBeat recorded 6 mentions for American Well and 5 mentions for Phreesia. American Well's average media sentiment score of 0.53 beat Phreesia's score of 0.16 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Phreesia	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Phreesia has a net margin of 2.06% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.22% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Phreesia	2.06%	5.22%	3.02%

American Well currently has a consensus target price of $9.50, suggesting a potential downside of 23.41%. Phreesia has a consensus target price of $14.07, suggesting a potential upside of 29.60%. Given Phreesia's stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37

56.1% of American Well shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 12.8% of American Well shares are held by company insiders. Comparatively, 5.2% of Phreesia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

American Well has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

Summary

Phreesia beats American Well on 12 of the 16 factors compared between the two stocks.

How does American Well compare to Veradigm?

American Well (NYSE:AMWL) and Veradigm (NASDAQ:MDRX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

In the previous week, American Well had 6 more articles in the media than Veradigm. MarketBeat recorded 6 mentions for American Well and 0 mentions for Veradigm. American Well's average media sentiment score of 0.53 beat Veradigm's score of 0.37 indicating that American Well is being referred to more favorably in the media.

Company	Overall Sentiment
American Well	Positive
Veradigm	Neutral

American Well has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market. Comparatively, Veradigm has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Veradigm has a net margin of 0.00% compared to American Well's net margin of -35.75%. Veradigm's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Veradigm	N/A	N/A	N/A

American Well presently has a consensus target price of $9.50, indicating a potential downside of 23.41%. Given American Well's stronger consensus rating and higher probable upside, equities analysts clearly believe American Well is more favorable than Veradigm.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veradigm	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Veradigm has higher revenue and earnings than American Well.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A
Veradigm	$1.53B	0.41	N/A	N/A	N/A

56.1% of American Well shares are owned by institutional investors. 12.8% of American Well shares are owned by company insiders. Comparatively, 2.3% of Veradigm shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

American Well beats Veradigm on 9 of the 14 factors compared between the two stocks.

How does American Well compare to Weave Communications?

Weave Communications (NYSE:WEAV) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Weave Communications has a net margin of -7.97% compared to American Well's net margin of -35.75%. Weave Communications' return on equity of -21.14% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Weave Communications	-7.97%	-21.14%	-8.41%
American Well	-35.75%	-30.12%	-22.30%

Weave Communications has a beta of 1.68, suggesting that its stock price is 68% more volatile than the broader market. Comparatively, American Well has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

Weave Communications currently has a consensus price target of $7.84, suggesting a potential upside of 6.16%. American Well has a consensus price target of $9.50, suggesting a potential downside of 23.41%. Given Weave Communications' stronger consensus rating and higher probable upside, research analysts plainly believe Weave Communications is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Weave Communications	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Weave Communications has higher earnings, but lower revenue than American Well. Weave Communications is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Weave Communications	$239.02M	2.47	-$28.05M	-$0.25	N/A
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A

In the previous week, American Well had 4 more articles in the media than Weave Communications. MarketBeat recorded 6 mentions for American Well and 2 mentions for Weave Communications. Weave Communications' average media sentiment score of 0.63 beat American Well's score of 0.53 indicating that Weave Communications is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Weave Communications	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

86.8% of Weave Communications shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 16.4% of Weave Communications shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Weave Communications beats American Well on 13 of the 16 factors compared between the two stocks.

How does American Well compare to National Research?

National Research (NASDAQ:NRC) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

National Research has higher earnings, but lower revenue than American Well. American Well is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Research	$137.39M	3.38	$11.60M	$0.25	81.64
American Well	$249.32M	0.82	-$95.70M	-$4.77	N/A

In the previous week, National Research had 4 more articles in the media than American Well. MarketBeat recorded 10 mentions for National Research and 6 mentions for American Well. National Research's average media sentiment score of 0.96 beat American Well's score of 0.53 indicating that National Research is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Research	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
American Well	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

47.3% of National Research shares are held by institutional investors. Comparatively, 56.1% of American Well shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 12.8% of American Well shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

National Research has a beta of 0.25, suggesting that its stock price is 75% less volatile than the broader market. Comparatively, American Well has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market.

National Research has a net margin of 4.18% compared to American Well's net margin of -35.75%. National Research's return on equity of 164.26% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Research	4.18%	164.26%	14.67%
American Well	-35.75%	-30.12%	-22.30%

National Research currently has a consensus target price of $26.00, suggesting a potential upside of 27.39%. American Well has a consensus target price of $9.50, suggesting a potential downside of 23.41%. Given National Research's higher possible upside, analysts plainly believe National Research is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Research	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

National Research beats American Well on 10 of the 14 factors compared between the two stocks.

Get American Well News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMWL vs. The Competition

Export

Metric	American Well	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$210.21M	$1.88B	$7.27B	$23.07B
Dividend Yield	N/A	3.95%	2.52%	3.72%
P/E Ratio	-2.60	21.81	275.36	28.54
Price / Sales	0.82	97.42	577.05	14.62
Price / Cash	N/A	32.12	27.30	19.30
Price / Book	0.83	6.25	10.75	4.71
Net Income	-$95.70M	-$19.09M	$3.50B	$1.07B
7 Day Performance	0.99%	-1.21%	-1.27%	-0.56%
1 Month Performance	-4.73%	-0.59%	-4.87%	-3.59%
1 Year Performance	112.40%	-19.81%	5.69%	7.41%

American Well Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMWL American Well	1.8339 of 5 stars	$12.40 -2.3%	$9.50 -23.4%	+113.5%	$210.21M	$249.32M	N/A	562
SOPH SOPHiA GENETICS	3.116 of 5 stars	$7.73 -5.8%	$10.00 +29.4%	+72.7%	$648.05M	$77.27M	N/A	415	Analyst Forecast Gap Up
PHR Phreesia	4.066 of 5 stars	$10.33 -0.4%	$14.00 +35.5%	-51.3%	$641.26M	$507.79M	60.77	1,789	Analyst Upgrade Gap Down
MDRX Veradigm	N/A	$5.00 flat	N/A	+5.0%	$611.50M	$1.53B	23.25	2,300
WEAV Weave Communications	1.8068 of 5 stars	$7.38 +0.2%	$7.84 +6.3%	+12.1%	$590M	$239.02M	N/A	904

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AMWL) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Well (AMWL) Competitors

AMWL vs. SOPH, PHR, MDRX, WEAV, and NRC

How does American Well compare to SOPHiA GENETICS?

Summary

How does American Well compare to Phreesia?

Summary

How does American Well compare to Veradigm?

Summary

How does American Well compare to Weave Communications?

Summary

How does American Well compare to National Research?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Well (AMWL) Competitors

AMWL vs. SOPH, PHR, MDRX, WEAV, and NRC

How does American Well compare to SOPHiA GENETICS?

Do analysts rate AMWL or SOPH?

Which has better valuation and earnings, AMWL or SOPH?

Which has more risk & volatility, AMWL or SOPH?

Does the media favor AMWL or SOPH?

Is AMWL or SOPH more profitable?

Do institutionals & insiders believe in AMWL or SOPH?

Summary

How does American Well compare to Phreesia?

Which has better earnings & valuation, AMWL or PHR?

Does the media prefer AMWL or PHR?

Is AMWL or PHR more profitable?

Do analysts prefer AMWL or PHR?

Do insiders and institutionals have more ownership in AMWL or PHR?

Which has more risk & volatility, AMWL or PHR?

Summary

How does American Well compare to Veradigm?

Does the media prefer AMWL or MDRX?

Which has more volatility and risk, AMWL or MDRX?

Is AMWL or MDRX more profitable?

Do analysts prefer AMWL or MDRX?

Which has better valuation & earnings, AMWL or MDRX?

Do insiders and institutionals have more ownership in AMWL or MDRX?

Summary

How does American Well compare to Weave Communications?

Is WEAV or AMWL more profitable?

Which has more risk and volatility, WEAV or AMWL?

Do analysts recommend WEAV or AMWL?

Which has preferable valuation & earnings, WEAV or AMWL?

Does the media favor WEAV or AMWL?

Do institutionals & insiders have more ownership in WEAV or AMWL?

Summary

How does American Well compare to National Research?

Which has better earnings & valuation, NRC or AMWL?

Does the media refer more to NRC or AMWL?

Do institutionals and insiders have more ownership in NRC or AMWL?

Which has more risk and volatility, NRC or AMWL?

Is NRC or AMWL more profitable?

Do analysts rate NRC or AMWL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools